| Financial Year |
March 31 2023 |
| Monetary Funds |
158,527,367.84 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
47,571,055.65 |
| Accounts Receivable |
596,920,180.94 |
| Advances to Suppliers |
37,802,074.88 |
| Other Receivables |
30,327,529.06 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
85,830,818.91 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
38,103,732.59 |
| Total Current Assets |
1,259,072,030.49 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
43,174,457.62 |
| Fixed Assetes |
1,269,640,771.43 |
| Under-construction Projects |
8,754,265.08 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
94,503,361.95 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
191,528,088.47 |
| Other Non-Current Assets |
2,634,636.32 |
| Sub-Total of Non-Current Assets |
1,620,546,860.96 |
| Total Assets |
2,879,618,891.45 |
| Short-Term Loans |
1,180,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
667,424,915.39 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
1,862,870.19 |
| Taxes Payable |
608,051.85 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
28,386,316.20 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
22,136,683.23 |
| Other Current Liabilities |
10,722,882.63 |
| Sub-Total of Current Liabilities |
1,928,834,559.38 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
26,096,878.55 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
432,245.57 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
53,521,213.61 |
| Total Liabilities |
1,982,355,772.99 |
| Paid-In Capital(Or Share Stock) |
245,912,337.00 |
| Capital Surplus |
782,205,308.39 |
| Surplus Reserve |
27,463,329.96 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-157,158,404.75 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
897,263,118.46 |
| Owner's Equity（Stockholder's Equity） |
897,263,118.46 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,879,618,891.45 |
